Genomics Grants

Sage Commons Congress Travel Awards

The organizers of the Sage Commons Congress, to held April 23-24, 2010 in San Francisco, are pleased to announce the availability of three travel grants, worth up to $800 each, to rising stars in the field of genomics based health research/drug discovery.

Travel Award registration deadline: March 15, 2010

Requirements:

You must be under 35 years old at the time of the Congress
You must submit the following:
A copy of your most recent C.V.
Sage Commons Congress Travel Application Form which includes:
Name and contact details of both applicant and sponsor
Details of your research experience (max 200 words) and academic/training background
An applicant statement (max 500 words) detailing what you would bring to the congress, how attending the Sage Congress will help you achieve your academic/professional/research goals and how you think Sage Bionetworks/Sage Commons platforms could be used to understand disease?
A letter of support from a sponsor confirming the applicant’s statement details.
You must attend the Congress to receive the award

Please submit your C.V. and application to: regoulding@gmail.com

Note: Please do not include any extra documentation, e.g., transcript, or letters of recommendation (beyond the letter of support), as they will not be reviewed.

The completed application must be received no later than MARCH 15, 2010. Incomplete applications will not be considered. Applications received after this date will NOT be considered.

Batten Disease Support and Research Association 2010 Request for Proposals

THe 2010 Request for Proposal is now available. Submitted proposals must be postmarked no later than 11:59PM , May 15, 2010. Emailed proposals will NOT be accepted. Inquiries may be directed to Lance W. Johnston, Executive Director, BDSRA, at 1-800-448-4570 or 740-927-4298. Email address: bdsra1@bdsra.org.

The Batten Disease Support and Research Association (BDSRA) is pleased to announce that limited funds are available to promote research and/or assist in a viable research project/s primarily for, but not limited to, development of novel therapeutic approaches to treatment for Neuronal Ceroid Lipofuscinosis, including the identification of bioactive compounds and characterization of cell-based therapeutic strategies, neuroimaging, proteomic and genomic approaches, and development of treatments that will alleviate the symptoms of Batten Disease. Also approaches exploring the neurobiology of NCL disease and determining the molecular pathogenesis in the CNS and further understanding the cell biology of the NCL proteins/enzymes. Proposals will be received for all forms of NCL with emphasis on CLN1, CLN2, and CLN3.

Multiyear proposals are generally discouraged unless there are extenuating circumstances or the study/project requires it.

BDSRA is including in its 2010 Request for Proposals, the establishment of a new postdoctoral fellowship. Proposals must include the percentage of time the candidate will expend on the project. Proposal must also include letter from established scientist or lab in which the posdtdoc will be working acknowledging the applicants position. Note: Funding for second and/or third year will be predicated on review of previous work and likelihood of achieving goals. Funding will not accompany if individual changes institution or lab unless preauthorized by BDSRA.

All grant award(s) must be used to cover direct costs of the project/ investigation and may not be used for indirect or overhead costs. All awards, including Postdoctoral fellowship, will be paid in six (6) month increments based on report submitted for review.

In the event of any changes, such changes will be announced on the BDSRA website - http://www.bdsra.org.

Batten Disease Support and Research Association
166 Humphries Dr.
Reynoldsburg, OH 43068

Request for Applications: Discovery of Susceptibility and Resistance Genes in Diabetic Kidney Disease

Diabetic Nephropathy is a complex phenotype likely caused by the interaction between
susceptibility alleles and environmental factors. There is evidence for a genetic susceptibility to
diabetic kidney disease, but despite intensive research efforts through candidate gene searches,
it has proved difficult to identify the causative genes.

Scope of RFA
JDRF announces a Request for Applications to participate in a collaborative effort to genotype
additional samples for genome-wide association analysis.

Applicants shall complete the rapid-decision application provided on the proposalCENTRAL
website no later than midnight EDT, January 5, 2010, using the application template provided
therein.

Juvenile Diabetes Research Foundation International
120 Wall Street, 19th Floor
New York, NY 10005-4001

Genetics/Genomics:
Elizabeth Roy
Phone: 212-479-7537
Email: eroy@jdrf.org